Galsulfase
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
Yes
Subsidy Information and Financing Scheme
No
Active ingredient: Galsulfase
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
Not Applicable
Additional Information
Galsulfase [Naglazyme] is approved for funding under the Rare Disease Fund (opens in new tab)
This section shows additional information related to the monograph such as drugs that are approved for funding under the Rare Disease Fund.